Triple Negative Breast Cancer (for tumors > 5 cm) for Breast Cancer
Study Summary
This trial will study whether the amount a tumor shrinks before surgery can predict how much of the tumor will remain after surgery.
- Breast Cancer
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Awards & Highlights
Trial Design
Find a site
Who is running the clinical trial?
Media Library
Frequently Asked Questions
Are there any positions available in this trial for new patients?
"Unfortunately, this particular trial is no longer recruiting patients. Although the last update was on May 15th, 2022, it was originally posted on June 15th of the same year. There are plenty of other trials, however; 7278 to be exact."
How many volunteers are taking part in this experiment?
"Unfortunately, this particular study is not currently looking for more participants. Although, it's worth mentioning that there are 5074 other trials related to triple negative breast neoplasms and 2204 trials concerning Triple Negative Breast Cancer (for tumors > 5 cm) that are actively recruiting patients right now."
Is this a groundbreaking clinical trial?
"Since 1997, there have been 2204 ongoing studies and 2978 completed trials for Triple Negative Breast Cancer (for tumors > 5 cm) across 87 countries and 4024 cities."
What is the most common treatment for Triple Negative Breast Cancer (for tumors > 5 cm)?
"While most often used to treat acute lymphoblastic leukemia, triple negative breast cancer can also help patients dealing with neoplasm metastasis, cyclophosphamide, lymphoma, and non-hodgkin."
Does the FDA condone Triple Negative Breast Cancer treatments for patients with tumors larger than 5 cm?
"For Triple Negative Breast Cancer (for tumors > 5 cm), our team has given it a score of 2. This is because while there is some data indicating that the intervention might be safe, at this stage there is no evidence to support efficacy."
Are there any other documented cases of research done on Triple Negative Breast Cancer (for tumors larger than 5 cm)?
"2204 studies are currently underway to research Triple Negative Breast Cancer (for tumors > 5 cm), with 507 of them in the critical Phase 3. Most of these investigations into Triple Negative Breast Cancer (for tumors > 5 cm) are based in Seattle, Washington, but there are 95200 locations running clinical trials for Triple Negative Breast Cancer (for tumors > 5 cm)."